emat

Buy Complete Report

Prix: €120 HT

Logo CreditCards Visa Logo CreditCards Mastercard

This report is accessible on EMAT, the reference database for private company acquisition multiples

 

 

► Subscribe to EMAT database

 

Sectors covered by our analysts

 

► Studies & indices published by Epsilon Research: Register to receive (free) publications updates

 

► Alert on reports published: Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

 

Transaction Multiples for the Valuation of Private Companies

Charnwood Molecular / Aurelia Bioscience

No EMAT : 114304
Announced Date : 21/06/2021
Type : Acquisition of Majority Stake
Deal Value : Yes
Acquirer : Charnwood Molecular

Target : Aurelia Bioscience
Country : England
Sector of activity :
  • Health, Pharmaceuticals & Biotechnology > Biotechnology
Business Description :
Aurelia Bioscience Ltd is a contract research organisation (CRO). > Specialising in bioassay development, pharmacological profiling, compound screening. > Serves SMEs, universities, medical...

Transaction multiples available
EV/
Sales
EV/
Gross Profit
EV/
EBITDA
EV/
EBIT
Eq/
PBT
P/E Price
to Book
Specific
multiple(s)
Historic
Current
Rating : **
Multiple available
n.s.   Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

  • Number of EMAT Reports / sub-sector « Biotechnology » = 42
Example of comparable transactions on EMAT (same sub-sector):
Date Acquirer Target Country Multiples See details
31/03/2021 Charles River Discovery Research Services UK Retrogenix England ** 114147
18/07/2023 Groupe Vabel Laboratoires Sarbec Nord * 113988

Source: Epsilon Research / EMAT

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

 

► Example of EMAT Report